Oncolytics Biotech Inc (NAS:ONCY)
$ 0.97 0 (0%) Market Cap: 75.59 Mil Enterprise Value: 62.70 Mil PE Ratio: 0 PB Ratio: 10.78 GF Score: 31/100

Q4 2019 Oncolytics Biotech Inc Earnings Call Transcript

Mar 05, 2020 / 10:00PM GMT
Release Date Price: $2.77 (+10.80%)
Operator

Good afternoon. My name is Mike, and I will be your conference operator today. At this time, I would like to welcome everyone to the Oncolytics Biotech Fourth Quarter and Year-end 2019 Results Conference Call. (Operator Instructions)

I will now turn the call over to your host, Michael Moore, Vice President, Investor Relations and Corporate Communications. Mr. Moore, please go ahead.

Michael Moore
Oncolytics Biotech Inc. - VP of IR & Corporate Communications

Thank you, Mike. Good afternoon, ladies and gentlemen, and thank you for joining us on our call today to discuss our fourth quarter and year-end 2019 financial results and corporate update, including an update on our clinical programs as well as our updated catalysts and milestones. With me on the call this afternoon from Oncolytics are Dr. Matt Coffey, President and Chief Executive Officer; and Kirk Look, Chief Financial Officer. On today's call, Dr. Coffey will review our clinical and operational progress since the beginning of 2019. And provide an update on our clinical development plans and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot